|1.||Woźniakowski, Grzegorz: 1 article (09/2015)|
|2.||Niczyporuk, Jowita Samanta: 1 article (09/2015)|
|3.||Kato, Takafumi: 1 article (03/2014)|
|4.||Kawana, Fusae: 1 article (03/2014)|
|5.||Sakai, Takuro: 1 article (03/2014)|
|6.||Ono, Yasuhiro: 1 article (03/2014)|
|7.||Yoshizawa, Ayako: 1 article (03/2014)|
|8.||Suganuma, Takeshi: 1 article (03/2014)|
|9.||Yoshizawa, Shuichiro: 1 article (03/2014)|
|10.||Baba, Kazuyoshi: 1 article (03/2014)|
|1.||Marek Disease (Marek's Disease)
08/01/2010 - "Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus."
04/01/1995 - "The field safety and efficacy of a bivalent Marek's disease (MD) vaccine (herpesvirus of turkeys + strain SB-1) administered in ovo were evaluated. "
04/01/1995 - "Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers."
10/01/1992 - "Previous studies have described an augmentation of avian leukosis virus (ALV)-induced lymphoid leukosis in chickens that were coinfected with a serotype 2 Marek's disease virus (MDV) strain, SB-1. "
07/01/1983 - "Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease."
01/01/1981 - "Furthermore, it was shown that although vaccination with SB-1 by itself did not protect against a highly virulent MD transplantable tumor, the combination of EBX and vaccination gave significant protection. "
10/01/1978 - "A series of experiments was conducted to study the in vivo protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. "
10/01/1978 - "Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus."
09/01/1978 - "The presence of Marek's disease tumor-associated surface antigen (MATSA) was demonstrated on spleen cells from P-line chickens inoculated 5--6 days earlier with herpesvirus of turkeys and SB-1 (a nononcogenic Marek's disease virus). "
09/01/2011 - "Here, we describe the staphylococcal bacteriophage Sb-1 - a key component of therapeutic phage preparation that was successfully used against staphylococcal infections during many years in the Former Soviet Union. "
09/01/2011 - "A case report describes a promising clinical response after phage application in patient with cystic fibrosis and indicates the efficacy of usage of Sb-1 phage against various staphylococcal infections."
|4.||Cystic Fibrosis (Mucoviscidosis)
07/01/2000 - "Two experiments were conducted using commercial broiler chickens to determine if Marek's disease (MD) vaccines HVT/SB-1 and HVT plus CVI-988 given either in ovo or at hatch adversely affected the efficacy of infectious bronchitis (IB) vaccines (Ark and Mass serotypes) given by eyedrop on the day of hatch. "
|2.||ganhuangenin (Sb 1)
|4.||RNA Helicases (RNA Helicase)
|5.||RNA (Ribonucleic Acid)
|6.||DNA (Deoxyribonucleic Acid)
|8.||Surface Antigens (Surface Antigen)